In Aftermath of NEJM Article, Critic Bailar Declares The Defeat Of Cancer Treatment
In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse
In This Issue: The controversy Over “Cancer Undefeated”
“Imaginary Treatments,” “Wonderful Cures”
Call to Shift Two-Thirds Of Funds a “Rubber Number,” Bailar Says
Broder Says No Thanks To Acknowledgement For Paper’s Title
Letters to The Editors: Donald Coffey Finds Sensationalism Hurts
Ellen Stoval Calls For More Funding for All Cancer Research
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs
- Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed
